NCT01371162View on ClinicalTrials.gov

A Study of RO5428029 in Healthy Volunteers and Patients With Chronic Hepatitis C

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Hepatitis C, Chronic, Healthy Volunteer
Interventions
DRUG

RO5428029

Multiple ascending doses

DRUG

placebo

multiple doses

Trial Locations (6)

2333

Leiden

34094

Montpellier

67064

Strasbourg

41-500

Chorzów

01-201

Warsaw

50-349

Wroclaw

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01371162 - A Study of RO5428029 in Healthy Volunteers and Patients With Chronic Hepatitis C | Biotech Hunter | Biotech Hunter